Pembrolizumab injection trials for Breast cancer

All Pembrolizumab injection trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Pembrolizumab injection for Breast cancer

• A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
  NCT05746897 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer
  NCT07679360 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
  NCT05973864 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations

Common questions

How many trials study Pembrolizumab injection for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.